Similarly, CRC cells carrying WT APC (HCT116) or CID partly containing APC mutation (DLD1) and WT HEK293T treated with HBX19818 did not suppress Wnt activation (Figures 5H, 5I, and S5A). This evidence concerns the gene APC and colorectal carcinoma.